Dermatologia Mediko Kirurgikoa eta Benereologia
Espezialitatea
Fundación Hospital Alcorcón
Alcorcón, EspañaFundación Hospital Alcorcón -ko ikertzaileekin lankidetzan egindako argitalpenak (21)
2024
-
2-Hydroxyethyl methacrylate (2-HEMA) sensitization, a global epidemic at its peak in Spain?
Contact Dermatitis, Vol. 90, Núm. 5, pp. 507-513
-
Measurement Assessment of Minimal Disease Activity In Psoriasis in Spain: A National Cross-Sectional Study
Actas Dermo-Sifiliograficas
-
Mohs micrographic surgery in immunosuppressed vs immunocompetent patients: Results of a prospective nationwide cohort study (REGESMOHS, Spanish registry of Mohs surgery)
Journal of the European Academy of Dermatology and Venereology
2023
-
Development and validation of a model to predict complex Mohs micrographic surgery in clinical practice: REGESMOSH scale
Journal of the European Academy of Dermatology and Venereology, Vol. 37, Núm. 8, pp. 1587-1594
2022
-
Complications Associated with Mohs Micrographic Surgery: Data from the Nationwide Prospective Cohort REGESMOHS
Dermatology, Vol. 238, Núm. 2, pp. 320-328
-
Incomplete Mohs surgery: a long-term, nationwide prospective cohort to describe recurrence rate and risk factors (REGESMOHS, Spanish Registry of Mohs Surgery)
Journal of the European Academy of Dermatology and Venereology
-
Risk of a Second Skin Cancer in a Cohort of Patients With Nonmelanoma Skin Cancer –Basal Cell Carcinoma or Squamous Cell Carcinoma-Treated With Mohs Micrographic Surgery: A National Prospective Cohort Study
Actas Dermo-Sifiliograficas, Vol. 113, Núm. 5, pp. 451-458
2021
-
Maintenance of response following discontinuation of guselkumab and secukinumab in Spanish patients who participated in the ECLIPSE study
Journal of the European Academy of Dermatology and Venereology
-
Mohs micrographic surgery in dermatofibrosarcoma protuberans: Rate and risk factors for recurrence in a prospective cohort study from the Spanish Registry of Mohs Surgery (REGESMOHS) and review of the literature
Experimental dermatology, Vol. 30, Núm. 5, pp. 717-722
2020
-
Real-world effectiveness and safety of apremilast in psoriasis at 52 weeks: a retrospective, observational, multicentre study by the Spanish Psoriasis Group
Journal of the European Academy of Dermatology and Venereology, Vol. 34, Núm. 12, pp. 2821-2829
-
State of the art of Mohs surgery for rare cutaneous tumors in the Spanish Registry of Mohs Surgery (REGESMOHS)
International Journal of Dermatology, Vol. 59, Núm. 3, pp. 321-325
2018
-
Are the Spanish baseline series markers sufficient to detect contact allergy to corticosteroids in Spain? A GEIDAC prospective study
Contact Dermatitis, Vol. 78, Núm. 1, pp. 76-82
-
Description of patients excluded for Mohs surgery after pre-surgical evaluation: data from the Regesmohs Spanish registry
Actas Dermo-Sifiliograficas, Vol. 109, Núm. 4, pp. 346-350
-
Differences of Mohs micrographic surgery in basal cell carcinoma versus squamous cell carcinoma
International Journal of Dermatology, Vol. 57, Núm. 11, pp. 1375-1381
-
Mohs micrographic surgery in the elderly: comparison of tumours, surgery and first-year follow-up in patients younger and older than 80 years old in REGESMOHS
Journal of the European Academy of Dermatology and Venereology, Vol. 32, Núm. 1, pp. 108-112
2017
-
Characterization of Surgical Procedures in the Spanish Mohs Surgery Registry (REGESMOHS) for 2013-2015
Actas Dermo-Sifiliograficas, Vol. 108, Núm. 9, pp. 836-843
-
Contact sensitization to limonene and linalool hydroperoxides in Spain: a GEIDAC* prospective study
Contact Dermatitis, Vol. 76, Núm. 2, pp. 74-80
2015
-
Description of Patients Undergoing Mohs Surgery in Spain: Initial Report on Data from the Spanish Registry of Mohs Surgery (REGESMOHS)
Actas Dermo-Sifiliograficas, Vol. 106, Núm. 7, pp. 562-568
2012
-
Intralesional rituximab in the treatment of indolent primary cutaneous B-cell lymphomas: An epidemiological observational multicentre study. The Spanish Working Group on Cutaneous Lymphoma
British Journal of Dermatology, Vol. 167, Núm. 1, pp. 174-179
2007
-
Genetic analysis of the GRM1 gene in human melanoma susceptibility
European Journal of Human Genetics, Vol. 15, Núm. 11, pp. 1176-1182